Cargando…

Effects of 1,25(OH)(2)D(3) and vitamin D receptor on peripheral CD4(+)/CD8(+) double‐positive T lymphocytes in a mouse model of systemic lupus erythematosus

This study aims to explore effects of 1,25(OH)(2)D(3) and vitamin D receptor (VDR) on peripheral CD4(+)/CD8(+) double‐positive (DP) T lymphocytes in systemic lupus erythematosus (SLE). MRL‐LPr/LPr mice with SLE (n = 20) and normal MRL mice (n = 20) were assigned into the control group (normal mice,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yan, Liao, Wang, He, Xiao‐Jie, Xiang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387123/ https://www.ncbi.nlm.nih.gov/pubmed/28063200 http://dx.doi.org/10.1111/jcmm.13037

Ejemplares similares

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Vitamin D (1,25-(OH)(2)D(3)) Improves Endothelial Progenitor Cells Function via Enhanced NO Secretion in Systemic Lupus Erythematosus
por: Huang, Zhenhua, et al.
Publicado: (2020)

1,25-(OH)(2)D(3)/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
por: Liu, Dan, et al.
Publicado: (2019)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

1,25(OH)(2)D(3) Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
por: Gardner, David H., et al.
Publicado: (2015)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs
por: Arora, Juhi, et al.
Publicado: (2022)

Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity
por: Pletz, Mathias W, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
por: Sollid, Stina T, et al.
Publicado: (2016)

The Effect of Vitamin D Prophylaxis on 25-OH Vitamin D Levels in Children
por: Gül, İhsan, et al.
Publicado: (2021)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Peripheral CD4(+)CD8(+) double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus
por: Chang, Kai, et al.
Publicado: (2023)

The Paracrine Feedback Loop Between Vitamin D(3) (1,25(OH)(2)D(3)) and PTHrP in Prehypertrophic Chondrocytes
por: Bach, Frances C, et al.
Publicado: (2014)

The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D(3) Targets HIF1α Protein in Osteoclasts
por: Sato, Yuiko, et al.
Publicado: (2014)

Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)(2)D(3): Is It Really the Vitamin D(3) Upregulated Protein?
por: Abu el Maaty, Mohamed A., et al.
Publicado: (2018)

Vitamin D(3) Metabolic Enzymes in the Porcine Uterus: Expression, Localization and Autoregulation by 1,25(OH)(2)D(3) In Vitro
por: Grzesiak, Malgorzata, et al.
Publicado: (2022)

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation
por: Kavadichanda, Chengappa, et al.
Publicado: (2023)

Association of Dietary Vitamin D Intake, Serum 25(OH)D(3), 25(OH)D(2) with Cognitive Performance in the Elderly
por: Wang, RuTong, et al.
Publicado: (2021)

CD3(+)CD8(+)CD28(−) T Lymphocytes in Patients with Lupus Nephritis
por: Żabińska, Marcelina, et al.
Publicado: (2016)

Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus
por: Wu, Yongkang, et al.
Publicado: (2014)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)(2)D(3) Induces Super-Enhancers Bound by VDR
por: Lu, Ming, et al.
Publicado: (2019)

Efficacy of two vitamin D immunoassays to detect 25-OH vitamin D2 and D3
por: Garnett, Emily, et al.
Publicado: (2019)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics
por: Castano, Luis, et al.
Publicado: (2022)

Increased 1,25(OH)(2)-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype
por: Vidal, Angela, et al.
Publicado: (2021)

Assessment of Abbott Architect 25-OH vitamin D assay in different levels of vitamin D
por: Avci, Esin, et al.
Publicado: (2020)

25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression
por: Ene, Corina-Daniela, et al.
Publicado: (2015)

Quantitative and qualitative analysis of CD4(+)CD25(+ )regulatory T cells in systemic lupus erythematosus patients
por: Bonelli, M, et al.
Publicado: (2005)

Expansion of regulatory GITR(+)CD25(low/-)CD4(+) T cells in systemic lupus erythematosus patients
por: Nocentini, Giuseppe, et al.
Publicado: (2014)

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)(2)D(3)
por: Kägi, Larissa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2b52bll9t5m3iln5l7kunm89rn